Imagine a highly contagious disease spreading rapidly across the U.S., exposing deep cracks in our public health system. That’s the grim reality we’re facing with the resurgence of measles, a disease once thought to be under control. But here’s where it gets controversial: after 25 years of maintaining measles elimination status, the U.S. is on the brink of losing it, and experts are fiercely divided on why—and what it means for our future.
In Seminole, Texas, the scene is all too familiar: signs directing people to measles testing in a hospital parking lot, a stark reminder of a disease we thought we’d left behind. Dr. Ralph Abraham, from the CDC, brushes it off as ‘the cost of doing business,’ citing porous borders and global travel. But Dr. Demetre Daskalakis, former director of the CDC’s National Center for Immunization and Respiratory Diseases, isn’t buying it. He boldly declares, ‘Elimination is already lost,’ pointing to systemic failures in our public health response. And this is the part most people miss: the resignation of top CDC officials, including Daskalakis, in protest of decisions that have weakened our ability to combat outbreaks.
Measles isn’t just a health issue—it’s a highly transmissible virus, with each infected person spreading it to 12–18 others. The virus lingers in the air for hours, making containment a daunting task. To achieve herd immunity, 95% of the population needs to be vaccinated. Yet, in 2025, the U.S. saw 2,242 confirmed cases, with 93% among the unvaccinated. Eleven percent required hospitalization, and three people died. The last time numbers were this high? 1991. And the cost? Staggering. Beyond the human toll, measles outbreaks cost millions—far more than vaccination programs. For instance, the 2025 outbreak alone cost an estimated $36.3 million, with some reviews suggesting it could be as high as $96.9 million.
Take South Carolina, where the measles epidemic has hit tourism hard. Dr. Annie Andrews, a local pediatrician, describes the drastic changes in her practice: triaging patients with rashes in their cars to prevent further spread. She now asks every patient about their ‘vaccine journey,’ a question born out of the alarming rise in unvaccinated individuals. She calls the disinformation campaigns ‘malpractice that is causing true harm.’ But here’s the kicker: she hopes the economic impact might finally ‘move the needle’ on public opinion.
The issue goes beyond measles. Governor Josh Green (D-HI), a physician, warns that dismantling public health infrastructure—like cutting Medicaid enrollment—is setting us up for disaster. His biggest fear? The next pandemic could make COVID-19 look like ‘a walk in the park.’ Daskalakis echoes this, blaming misinformation campaigns for eroding trust in vaccines, particularly in vulnerable communities. Take the measles outbreak in an Orthodox Jewish community in New York, fueled by false claims about vaccine safety. Or Texas, where Robert F. Kennedy Jr. promoted unproven treatments like inhaled steroids and antibiotics instead of the MMR vaccine, spreading dangerous myths.
And this is where it gets even more contentious: Kennedy’s actions have amplified skepticism, but some argue it’s a matter of ‘personal freedom.’ Dr. Abraham suggests parents should be respected for choosing not to vaccinate their children. But what about the immunocompromised or infants too young to be vaccinated? Their lives are at risk because of these choices. Organizations like Grandparents for Vaccines share heart-wrenching stories of families devastated by preventable diseases before vaccines were widespread. One such story is Therese’s sister, Nancy, who developed encephalitis after measles, leaving her permanently disabled.
Kennedy’s influence doesn’t stop there. He’s pushed for separating the MMR vaccine into individual components, a move that would be costly and impractical. Meanwhile, many states are rejecting the CDC’s new vaccine schedule, opting instead for the American Academy of Pediatrics’ recommendations. A lawsuit filed by major health organizations aims to block Kennedy’s and the CDC’s recent changes, highlighting the deep divisions in our approach to public health.
So, here’s the question: Is losing measles elimination status just ‘the cost of doing business,’ as Abraham suggests, or is it a symptom of a much larger failure in our public health system? And what does this mean for our ability to handle future outbreaks? Let’s start the conversation—what do you think? Is it a matter of freedom, or are we risking lives for the sake of misinformation?
